₹26.42
▲ +0.42 +1.62%
16 Jun 2026
BSE Listed · Pharmaceuticals
Veerhealth Care Limited (511523)
Volume: 2,23,008Avg Vol 1W: 1,86,794Avg Vol 1M: 1,40,38752W Range:₹14.98₹26.42
Key Ratios
Updated just nowMarket Cap—
Current Price₹26.42
Previous Close₹26
High / Low (52w)₹26.42 / ₹14.98
Volume2,23,008
Avg Vol (1W)1,86,794
Avg Vol (1M)1,40,387
Stock P/E61.2
Book Value₹11.46
Dividend Yield—
ROE1.77%
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹-0.18
P/B2.31
Debt / Equity0.11
50 DMA₹22.31
200 DMA₹19.65
Day change+1.62%
Price Chart
₹26.42▲ 46.53% · 1Y
2025-06-172026-06-16
20-day avg volume: 1.5L shares
Pros
- Company is almost debt-free.
- Revenue grew 22% YoY.
Cons
- Stock trades at a high P/E of 61.
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sept 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sept 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹17 Cr | ₹7 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹4 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr |
| EBITDA | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr |
| EPS | -0.18 | 0.2 | 0.13 | 0.12 | -0.05 | 0.04 | 0.15 | 0.06 | -0.26 | 0.09 | 0.19 | 0.33 | 1.01 | 0.46 | 0.19 | 0.12 | -0.5 | 0.25 | 0.04 | 0.07 | -0.29 | 0.15 | 0.61 | 0.09 | -0.94 |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Revenue | ₹18 Cr | ₹15 Cr | ₹15 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr |
| EBITDA | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | 0.2 | 0.21 | 1.52 | -0.11 | 0.55 | 0.46 |
Balance Sheet
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Total Assets | ₹34 Cr | ₹28 Cr | ₹25 Cr | ₹20 Cr | ₹19 Cr | ₹18 Cr |
| Total Liabilities | ₹12 Cr | ₹6 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr |
| Equity | ₹22 Cr | ₹22 Cr | ₹21 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
| Total Debt | ₹4 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr |
Cash Flow
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹3 Cr | ₹-1 Cr | ₹2 Cr | ₹1 Cr |
| Investing | ₹-8 Cr | ₹0 Cr | ₹-2 Cr | ₹-1 Cr | ₹0 Cr |
| Financing | ₹10 Cr | ₹-6 Cr | ₹6 Cr | ₹0 Cr | ₹-1 Cr |
| Free Cash Flow | ₹0 Cr | ₹3 Cr | ₹0 Cr | ₹2 Cr | ₹1 Cr |
Shareholding
Promoter 31.5% Institutions 0% Public 68.5%
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search